Metformin use and survival from lung cancer: A population-based cohort study
Open Access
- 1 April 2016
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 94, 35-39
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prognosis of small cell lung cancer patients with diabetes treated with metforminClinical and Translational Oncology, 2015
- Metformin use improves the survival of diabetic combined small-cell lung cancer patientsTumor Biology, 2015
- The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetesBreast Cancer Research and Treatment, 2015
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With DiabetesJournal of Clinical Oncology, 2013
- Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPKBritish Journal of Cancer, 2013
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancerBritish Journal of Cancer, 2012
- Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetesCancer, 2011
- Understanding the benefit of metformin use in cancer treatmentBMC Medicine, 2011
- Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153Neoplasma, 2011
- Metformin Prevents Tobacco Carcinogen–Induced Lung TumorigenesisCancer Prevention Research, 2010